17β-Estradiol inhibits vascular smooth muscle cell migration via up-regulation of striatin protein

References

• Hodis HN, Mack WJ, Lobo RA, et al. Estrogen in the prevention of atherosclerosis: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2001;135:939–53
   PubMed Web of Science ®Google Scholar
• Billon-Gales A, Fontaine C, Douin-Echinard V, et al. Endothelial estrogen receptor-alpha plays a crucial role in the atheroprotective action of 17beta-estradiol in low-density lipoprotein receptor-deficient mice. Circulation 2009;120:2567–76
   PubMed Web of Science ®Google Scholar
• Torii R, Shiomi M, Ito T, et al. Cholesterol-fed ovariectomized monkeys are good animal models for human atherosclerosis of postmenopausal women. Primates 2003;44:247–52
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321–33
   PubMed Web of Science ®Google Scholar
• Karas R, Clarkson TB. Considerations in interpreting the cardiovascular effects of hormone replacement observed in WHI: timing is everything. Menopausal Med 2003;10:8–12
   Google Scholar
• Schierbeck LL, Rejnmark L, Tofteng CL, et al. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ 2012;345:e6409
   PubMed Web of Science ®Google Scholar
• Hopkins PN. Molecular biology of atherosclerosis. Physiol Rev 2013;93:1317–542
   PubMed Web of Science ®Google Scholar
• Zhou K, Gao Q, Zheng S, Pan S, Li P, et al. 17Beta-estradiol induces vasorelaxation by stimulating endothelial hydrogen sulfide release. Mol Hum Reprod 2013;19:169–76
   PubMed Web of Science ®Google Scholar
• Kublickiene K, Fu XD, Svedas E, et al. Effects in postmenopausal women of estradiol and medroxyprogesterone alone and combined on resistance artery function and endothelial morphology and movement. J Clin Endocrinol Metab 2008;93:1874–83
   PubMed Web of Science ®Google Scholar
• Simoncini T, Scorticati C, Mannella P, et al. Estrogen receptor alpha interacts with Galpha13 to drive actin remodeling and endothelial cell migration via the RhoA/Rho kinase/moesin pathway. Mol Endocrinol 2006;20:1756–71
   PubMed Web of Science ®Google Scholar
• Jiang P, Xu J, Zheng S, Huang J, Xiang Q, et al. 17Beta-estradiol down-regulates lipopolysaccharide-induced MCP-1 production and cell migration in vascular smooth muscle cells. J Mol Endocrinol 2010;45:87–97
   PubMed Web of Science ®Google Scholar
• Bernelot Moens SJ, Schnitzler GR, Nickerson M, et al. Rapid estrogen receptor signaling is essential for the protective effects of estrogen against vascular injury. Circulation 2012;126:1993–2004
   PubMed Web of Science ®Google Scholar
• Lu Q, Pallas DC, Surks HK, et al. Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor alpha. Proc Natl Acad Sci USA 2004;101:17126–31
   PubMed Web of Science ®Google Scholar
• Craige SM, Chen K, Pei Y, et al. NADPH oxidase 4 promotes endothelial angiogenesis through endothelial nitric oxide synthase activation. Circulation 2011;124:731–40
   PubMed Web of Science ®Google Scholar
• Fu X, Zhou K, Gao Q, et al. 17Beta-estradiol attenuates atherosclerosis development: the possible role of hydrogen sulfide. Int J Cardiol 2013;167:1061–3
   PubMed Web of Science ®Google Scholar
• Xing D, Nozell S, Chen YF, et al. Estrogen and mechanisms of vascular protection. Arterioscler Thromb Vasc Biol 2009;29:289–95
   PubMed Web of Science ®Google Scholar
• Mendelsohn ME, Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science 2005;308:1583–7
   PubMed Web of Science ®Google Scholar
• Moreno CS, Park S, Nelson K, et al. WD40 repeat proteins striatin and S/G(2) nuclear autoantigen are members of a novel family of calmodulin-binding proteins that associate with protein phosphatase 2A. J Biol Chem 2000;275:5257–63
   PubMed Web of Science ®Google Scholar
• Kappert K, Caglayan E, Huntgeburth M, et al. 17Beta-estradiol attenuates PDGF signaling in vascular smooth muscle cells at the postreceptor level. Am J Physiol Heart Circ Physiol 2006;290:H538–46
   PubMed Web of Science ®Google Scholar
• Jiang X, Zhang Y, Hou D, et al. 17Beta-estradiol inhibits oleic acid-induced rat VSMC proliferation and migration by restoring PGC-1alpha expression. Mol Cell Endocrinol 2010;315:74–80
   PubMed Web of Science ®Google Scholar
• Pojoga LH, Coutinho P, Rivera A, et al. Activation of the mineralocorticoid receptor increases striatin levels. Am J Hypertens 2011;25:243–9
   PubMed Web of Science ®Google Scholar
• Gros R, Ding Q, Liu B, et al. Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation. Am J Physiol Cell Physiol 2013;304:C532–40
   PubMed Web of Science ®Google Scholar
• Yamanaka R, Otsuka F, Nakamura K, et al. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension. Hypertens Res 2010;33:435–45
   PubMed Web of Science ®Google Scholar
• Anjum R, Blenis J. The RSK family of kinases: emerging roles in cellular signalling. Nat Rev Mol Cell Biol 2008;9:747–58
   PubMed Web of Science ®Google Scholar
• Finnberg N, El-Deiry WS. Activating FOXO3a, NF-kappaB and p53 by targeting IKKs: an effective multi-faceted targeting of the tumor-cell phenotype? Cancer Biol Ther 2004;3:614–16
   PubMed Web of Science ®Google Scholar
• Marais R, Wynne J, Treisman R. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 1993;73:381–93
   PubMed Web of Science ®Google Scholar
• Ortmann J, Veit M, Zingg S, et al. Estrogen receptor-alpha but not -beta or GPER inhibits high glucose-induced human VSMC proliferation: potential role of ROS and ERK. J Clin Endocrinol Metab 2011;96:220–8
   PubMed Web of Science ®Google Scholar
• Wang TH, Tan Z, Fu XD, et al. [Effect of ERK on 17beta-estradiol-induced inhibition of VSMC proliferation in rats after vascular injury]. Sheng Li Xue Bao 2003;55:411–16
   PubMedGoogle Scholar
• Ding Q, Gros R, Limbird LE, et al. Estradiol-mediated ERK phosphorylation and apoptosis in vascular smooth muscle cells requires GPR 30. Am J Physiol Cell Physiol 2009;297:C1178–87
   PubMed Web of Science ®Google Scholar
• Fu XD, Simoncini T. Non-genomic sex steroid actions in the vascular system. Semin Reprod Med 2007;25:178–86
   PubMed Web of Science ®Google Scholar